GAVISCONELL MENTHE sugar-free, oral suspension in a single-dose sachet sweetened with sodium saccharin 24 sachets of 10 ml
Active ingredients: Sodium alginate, Sodium bicarbonate
Commercialized according to BDPM
Oral suspension24 sachets of 10 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GAVISCONELL MENTHE SANS SUCRE, suspension buvable en sachet-dose édulcorée à la saccharine sodique
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 24 sachet(s) aluminium polyéthylène de 10 ml
- Marketing authorisation holder
- RECKITT BENCKISER HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 3 Apr 2012
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62292134CIP73385176CIP133400933851767Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BICARBONATE DE SODIUMsuspension | 267,00 mg · un sachet-dose | SA |
| ALGINATE DE SODIUMsuspension | 500,00 mg · un sachet-dose | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.